Annovis Bio Inc. (ANVS) NEW YORK STOCK EXCHANGE INC.
$11.90 (0.13) (-1.08%)
Market Cap: $127.28M
As of 03/28/24 04:00 PM EDT. Market closed.
Annovis Bio Inc. (ANVS)
NEW YORK STOCK EXCHANGE INC.
$11.90
(0.13) (-1.08%)
Market Cap: $127.28M
As of 03/28/24 04:00 PM EDT. Market closed.
annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders. the company is also developing anvs405 for protecting the brain after ... read more
annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders. the company is also developing anvs405 for protecting the brain after traumatic brain injury and/or stroke; and anvs301, which is in phase i clinical trials to increase cognitive capability in later stages of ad and dementia. annovis bio, inc. was founded in 2008 and is based in berwyn, pennsylvania. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
White Mark K. | Director | Nov 20, 2023 | Option Exercise | $6.10 | 1,990 | 12,139 | 61,167 | Nov 22, 2023, 04:27 PM |
Hoffman Michael B | Director | Nov 20, 2023 | Option Exercise | $6.10 | 163,880 | 999,668 | 223,357 | Nov 22, 2023, 04:24 PM |
Maccecchini Maria-Luisa | President and CEO | Nov 20, 2023 | Option Exercise | $6.10 | 40,970 | 249,917 | 1,098,459 | Nov 22, 2023, 04:23 PM |
Hagopian Henry III | Chief Financial Officer | Nov 20, 2023 | Option Exercise | $6.10 | 820 | 5,002 | 1,820 | Nov 22, 2023, 04:21 PM |
McCarthy Reid | Director | Nov 20, 2023 | Option Exercise | $6.07 | 824 | 5,002 | 8,129 | Nov 21, 2023, 02:33 PM |
Hoffman Michael B | Director | Nov 20, 2023 | Option Exercise | $6.07 | 164,745 | 1,000,002 | 224,222 | Nov 21, 2023, 02:32 PM |
White Mark K. | Director | Nov 20, 2023 | Option Exercise | $6.07 | 2,000 | 12,140 | 61,177 | Nov 21, 2023, 02:31 PM |
Maccecchini Maria-Luisa | President and CEO | Nov 20, 2023 | Option Exercise | $6.07 | 41,186 | 249,999 | 1,098,675 | Nov 21, 2023, 02:30 PM |
Hagopian Henry III | Chief Financial Officer | Nov 20, 2023 | Option Exercise | $6.07 | 824 | 5,002 | 1,824 | Nov 21, 2023, 02:29 PM |
Bruck Claudine | Director | Nov 20, 2023 | Option Exercise | $6.07 | 1,000 | 6,070 | 7,567 | Nov 21, 2023, 02:27 PM |
White Mark K. | Director | Apr 07, 2023 | Option Exercise | $12.61 | 3,000 | 37,830 | 59,177 | Apr 11, 2023, 09:14 PM |
Bruck Claudine | Director | Apr 07, 2023 | Option Exercise | $12.61 | 500 | 6,305 | 6,567 | Apr 11, 2023, 09:11 PM |
Hagopian Henry III | Chief Financial Officer | Apr 07, 2023 | Option Exercise | $12.61 | 1,000 | 12,610 | 1,000 | Apr 11, 2023, 09:08 PM |
Hoffman Michael B | Director | Apr 07, 2023 | Option Exercise | $12.61 | 59,477 | 750,005 | 59,477 | Apr 11, 2023, 09:06 PM |
McCarthy Reid | Director | Apr 07, 2023 | Option Exercise | $12.61 | 476 | 6,002 | 7,305 | Apr 11, 2023, 09:05 PM |
Maccecchini Maria-Luisa | President and CEO | Apr 07, 2023 | Option Exercise | $12.61 | 20,000 | 252,200 | 1,060,489 | Apr 11, 2023, 09:03 PM |
Maccecchini Maria-Luisa | President and CEO | Feb 06, 2023 | Option Exercise | $0.14 | 52,755 | 7,386 | 1,040,489 | Feb 08, 2023, 05:11 PM |
Maccecchini Maria-Luisa | President and CEO | Jan 14, 2022 | Option Exercise | $0.14 | 32,959 | 4,614 | 987,734 | Jan 18, 2022, 09:08 PM |
Hoffman Michael B | Director | Jan 04, 2022 | Option Exercise | $19.78 | 6,748 | 133,475 | 1,416,283 | Jan 05, 2022, 07:41 PM |
Hoffman Michael B | Director | Jan 04, 2022 | Option Exercise | $3.59 | 37,142 | 133,485 | 1,416,373 | Jan 05, 2022, 07:41 PM |
Bruck Claudine | Director | Oct 11, 2021 | Buy | $27.66 | 181 | 5,006 | 6,067 | Oct 13, 2021, 04:03 PM |
White Mark K. | Director | Oct 12, 2021 | Buy | $27.40 | 5,000 | 137,000 | 56,177 | Oct 13, 2021, 04:02 PM |
Maccecchini Maria-Luisa | PRESIDENT AND CEO | Oct 11, 2021 | Buy | $27.61 | 18,000 | 496,980 | 976,775 | Oct 13, 2021, 04:00 PM |
McCarthy Reid | Director | Aug 19, 2021 | Buy | $37.61 | 500 | 18,805 | 6,829 | Aug 23, 2021, 11:36 AM |
Hoffman Michael B | Director | Jan 31, 2020 | Option Exercise | $4.80 | 55,884 | 268,243 | 1,400,175 | Feb 05, 2020, 06:05 AM |
Hoffman Michael B | Director | Jan 31, 2020 | Buy | $6.00 | 33,333 | 199,998 | 47,619 | Feb 05, 2020, 06:05 AM |
Whelan, Jr. Robert M. | Director | Jan 31, 2020 | Option Exercise | $4.80 | 11,176 | 53,645 | 95,700 | Feb 05, 2020, 06:05 AM |
Whelan, Jr. Robert M. | Director | Jan 31, 2020 | Buy | $6.00 | 25,000 | 150,000 | 25,000 | Feb 05, 2020, 06:05 AM |
Bruck Claudine | Director | Jan 31, 2020 | Option Exercise | $4.80 | 1,117 | 5,362 | 5,886 | Feb 05, 2020, 06:04 AM |
Bruck Claudine | Director | Jan 31, 2020 | Buy | $6.00 | 800 | 4,800 | 800 | Feb 05, 2020, 06:04 AM |
Maccecchini Maria-Luisa | President and CEO | Jan 31, 2020 | Buy | $6.00 | 1,600 | 9,600 | 207,942 | Feb 05, 2020, 06:03 AM |
McGroarty Jeffrey Brian | Chief Financial Officer | Feb 03, 2020 | Buy | $7.15 | 19,500 | 139,428 | 52,833 | Feb 05, 2020, 06:03 AM |
McGroarty Jeffrey Brian | Chief Financial Officer | Jan 31, 2020 | Buy | $6.00 | 33,333 | 199,998 | 33,333 | Feb 05, 2020, 06:03 AM |
White Mark K. | Director | Jan 31, 2020 | Option Exercise | $4.80 | 3,252 | 15,610 | 51,177 | Feb 05, 2020, 06:02 AM |
White Mark K. | Director | Jan 31, 2020 | Buy | $6.00 | 1,734 | 10,404 | 1,734 | Feb 05, 2020, 06:02 AM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 285,347 | 0.01% | -4.88% | Other |
BLACKROCK INC. | 95,984 | 0.00005% | -0.31% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 68,776 | 0.00013% | 22.73% | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View